Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Short-term Investments (2016 - 2026)

Cryo Cell International's Short-term Investments history spans 16 years, with the latest figure at $2.7 million for Q1 2026.

  • Quarterly results put Short-term Investments at $2.7 million for Q1 2026, down 18.61% from a year ago — trailing twelve months through Feb 2026 was $2.7 million (down 18.61% YoY), and the annual figure for FY2025 was $3.0 million, up 1.43%.
  • Short-term Investments for Q1 2026 was $2.7 million at Cryo Cell International, down from $3.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.3 million in Q2 2025 to a low of $17620.0 in Q4 2022.
  • The 5-year median for Short-term Investments is $840277.0 (2023), against an average of $1.5 million.
  • The sharpest move saw Short-term Investments crashed 76.64% in 2022, then skyrocketed 3158.7% in 2023.
  • Year by year, Short-term Investments stood at $17620.0 in 2022, then skyrocketed by 3158.7% to $574183.0 in 2023, then soared by 411.19% to $2.9 million in 2024, then grew by 1.43% to $3.0 million in 2025, then fell by 10.97% to $2.7 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $2.7 million, $3.0 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.